Search Results: lung cancer (124)

In an unprecedented and strategic move, the U.S. Food and Drug Administration (FDA) has granted permission for the temporary import of an unapproved Chinese cancer drug. The decision comes amid a growing shortage of vital cancer drugs in the US, notably cisplatin, a widely used chemotherapy medication. The crisis has prompted the FDA to consider unconventional approaches, and this move stands as testament to that flexibility.

CytoMed Therapeutics has developed a revolutionary new cancer treatment that uses modified white blood cells from healthy donors to recognize and destroy cancer cells. The therapy is being trialled in Singapore on patients with the most common types of cancer. If successful, the treatment could lead to more efficient and accessible CAR-T cell therapies for a range of solid and blood cancers.